Affiliation:
1. Department of Nephrology , The No. 1 People’s Hospital of Pinghu , Pinghu City , Zhejiang Province 314200 , PR China
2. Department of General Practice Medicine , The No. 1 People’s Hospital of Pinghu , Pinghu City , Zhejiang Province 314200 , PR China
Abstract
Abstract
Objective
To investigate the epithelial nitric oxide synthases (eNOS) 894 G < T polymorphism and diabetic nephropathy (DN) susceptibility by pooling the open published data.
Methods
Studies relevant to eNOS 894 G < T polymorphism and DN susceptibility published in PubMed, EMBASE, Medline, CNKI, and Wanfang databases were systematically screened by using the text words of endothelial nitric oxide synthase, eNOS, NOS-3, G894T, rs179983, polymorphism, diabetic nephropathy, and DN. The correlation between eNOS 894 G < T polymorphism and DN susceptibility was demonstrated by odds ratio (OR) and corresponding 95% confidence interval (95% CI). The data were combined through fixed or random effect model according to statistical heterogeneity. The publication bias was assessed by Begg’s funnel plot and Egger’s line regression test.
Results
Twenty-six case-control studies relevant to eNOS 894 G < T polymorphism and DN susceptibility were identified by electronic searching of the related databases. Type 2 diabetes mellitus (T2MD) patients with T allele had increased susceptibility to DN compared with G allele under homologous gene model (TT vs GG) (OR = 1.40, 95% CI: 1.16–1.69, p = 0.001), dominant gene model (TT + GT) vs GG (OR = 1.61, 95% CI: 1.30–2.00, p = 0.000) and recessive gene model TT vs (GT + GG) (OR = 1.39, 95% CI: 1.16–1.66, p = 0.000). Publication bias was not statistically significant for homologous and recessive gene model.
Conclusion
Based on the present evidence, DN risk was increased in T2MD cases with T allele compared to G allele.
Subject
Clinical Biochemistry,Molecular Medicine,Biochemistry
Reference36 articles.
1. Soskić SS, Dobutović BD, Sudar EM, Obradović MM, Nikolić DM, Djordjevic JD, et al. Regulation of inducible nitric oxide synthase (iNOS) and its potential role in insulin resistance, diabetes and heart failure. Open Cardiovasc Med J. 2011;5:153–63.
2. Lizicarova D, Krahulec B, Hirnerova E, Gaspar L, Celecova Z. Risk factors in diabetic nephropathy progression at present. Bratisl Lek Listy. 2014;115(8):517–21.
3. Moţa E, Panduru MN, Popa SG, Moţa M. Risk factors for diabetic nephropathy: intrinsic or extrinsic renal. Rom J Intern Med. 2009;47(4):397–401.
4. Ayodele OE, Alebiosu CO, Salako BL. Diabetic nephropathy-a review of the natural history, burden, risk factors and treatment. J Natl Med Assoc. 2004;96(11):1445–54.
5. Albert C, Kube J, Albert A, Schanze D, Zenker M, Mertens PR. Cubilin single nucleotide polymorphism variants are associated with macroangiopathy while a matrix Metalloproteinase-9 single nucleotide polymorphism flip-flop may indicate susceptibility of diabetic nephropathy in type-2 diabetic patients. Nephron. 2019;141(3):156–65.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献